- If put in the NHS, GcMAF would save 120,000 lives a year.
- GcMAF is a safe, natural human protein inside 5 billion people.
- Cancer and 50 other diseases block its production in the body.
- 11,500 patients have taken it
- 9,000 successes
- 400 doctors support it
- There are over 1,000 GcMAF papers on Google Scholar
- 300 scientists have written 150 peer reviewed scientific research papers, published in the worlds top scientific journals.
- We had 4 scientists, the most senior being Professor Marco Ruggiero MD, 7 doctors, two ultrasound staff, 4 nurses, and admin staff when the MHRA closed us down
GcMAF successfully treats all tumour cancers, which is 90% of cancers
75% of terminal stage IV patients lives saved in our clinics.
The American National Library of Medicine, or Pubmed has 70 GcMAF papers peer reviewed for the second time:
12659668 Neoplasia, 2003
- By seven cancer research institutes from three nations
- It lists six attacks of GcMAF on cancer, more than any other molecule.
20976141 PlosOne 2010 by three USA cancer institutes
- Another three attacks on cancer by GcMAF.
20855083 Journal of Surgical Research 2010
- by five of Japan’s cancer research institutes, including the prestigious Atomic Bomb Biomedical Institute of Nagasaki University
- GcMAF reduces liver cancer tumours by 90% in three weeks; picture in page 4; antiangiogenetic activity (cancer tumour cannot grow above 1 mm, and it kills tumours).
Immuno Biotech Ltd (IBL) has 33 GcMAF scientific research papers from 2013 to 2014, all peer-reviewed and published in top scientific journals. vgcmaf.se
24982371 Anticancer Research Journal 2014. University of Florence, Immuno Biotech. Gcmaf reduces tumours by 25% in the first week. Similar results across 40 clinic patients,
IBL’s GcMAF (Goleic) become the first treatment to turn off the HER2 oncogene, a mutated gene found in 20% of cancer patients that perpetually generates cancer throughout the patient’s short life.
25675551 Anticancer Research 2014 conference in Greece.
- HER2 before and after biopsies stored at Careggi Hospital, Florence, Italy.
See www.gcmaf.se – click “why us” at the top
- You’ll find over 50 patient histories-recoveries from cancer and 50 incurable diseases.
And click videos
- a dozen videos of patients
The worlds only survivor from Ovarian HGSC peritoneal cancer: YouTube.com search Teri Davis Newman.
- we have contact details for all 11,500 of these; you can meet them
- 200 in England.
- About 200 cancer patients were killed by the MHRA when they banned GcMAF
240 doctors obtained GcMAF directly from us, and about 100 recommended GcMAF. We have contact details.
We were giving 25% away free to those who couldn’t afford it.
The MHRA,with GSK Pharmaceutical directors on its board, will never licence a safe natural protein. So we had to proceed without a license, secure in the knowledge that GSK’s Avandia had killed 83,000, and they got off without even a slapped wrist from the MHRA. GcMAF is completely safe. So we though we were fine.
In a shocking abuse of our laws by the corrupt MHRA, we, IBL, have been utterly destroyed by the MHRA. It has big pharmaceutical directors on its board, GcMAF has been concealed for 25 years, the MHRA asked for a 14 year prison sentence for David Noakes (IBL’s CEO) in the UK and put him and one of our four scientists into Wandsworth prison. The MHRA has asked for a conccurrent 12 year sentence in France, to conceal it for another 25 years.